Filtered By:
Cancer: Lung Cancer

This page shows you your search results in order of relevance. This is page number 10.

Order by Relevance | Date

Total 241 results found since Jan 2013.

Bronchiectasthma and asthmectasis!
Respiratory disease can be considered as a species in constant evolution. Due to population growth and ageing only, and apart from the current 1.1 billion smokers, there have never been more respiratory patients ever in history than today [1]. With the latest World Health Organization (WHO) worldwide estimates of 400 million individuals with rhinitis, 334 million asthmatics, 328 million chronic obstructive pulmonary disease (COPD) patients and over 100 million with sleep apnoea, there is plenty of opportunity for the concurrence of two or more respiratory diseases in the same person. Not surprisingly, it is now commonplace...
Source: European Respiratory Journal - May 30, 2016 Category: Respiratory Medicine Authors: Soriano, J. B., Serrano, J. Tags: Asthma and allergy, CF and non-CF bronchiectasis Editorials Source Type: research

Diagnoses and Management of Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: Reactions to Taxanes and Monoclonal Antibodies
Abstract Due to the increase in utilization of chemotherapies and antibodies, drug hypersensitivity reactions have increased dramatically worldwide, preventing the use of first-line therapies and impacting patients’ survival and quality of life. Some of the more frequently used medications in cancer include taxanes for ovarian, lung, breast, and prostate cancers. Monoclonal antibodies are used in the treatment of neoplastic, autoimmune, and inflammatory diseases, and their clinical applications are becoming broader. Monoclonal antibody targets include CD20, HER-2, EGFR, IL-6 receptor, TNF-α, CD30, VEGF-A, IgE, ...
Source: Clinical Reviews in Allergy and Immunology - June 7, 2016 Category: Allergy & Immunology Source Type: research

Majority of never-smokers with airflow limitation do not have asthma: the Copenhagen General Population Study
Conclusions Majority of NS+AFL–A do not seem to have undiagnosed asthma and may instead have airflow limitation caused by other risk factors.
Source: Thorax - June 13, 2016 Category: Respiratory Medicine Authors: Colak, Y., Afzal, S., Nordestgaard, B. G., Lange, P. Tags: Lung neoplasms, Epidemiologic studies, Pneumonia (infectious disease), TB and other respiratory infections, Lung cancer (oncology), Ischaemic heart disease, Asthma, Lung cancer (respiratory medicine), Pneumonia (respiratory medicine) Paediatric lung dis Source Type: research

Lung Cancer Screening Lung Cancer Screening
This review discusses current screening recommendations for the early detection of lung cancer and explores the potential benefits and risks.Current Opinion in Pulmonary Medicine
Source: Medscape Allergy Headlines - August 8, 2016 Category: Allergy & Immunology Tags: Pulmonary Medicine Journal Article Source Type: news

Lung Cancer in COPD, It Is Not Just the Cigarette Smoke Lung Cancer in COPD, It Is Not Just the Cigarette Smoke
The development of lung cancer in patients with COPD has been linked with tobacco exposure, but other factors may also play a role.Current Opinion in Pulmonary Medicine
Source: Medscape Allergy Headlines - August 22, 2016 Category: Allergy & Immunology Tags: Pulmonary Medicine Journal Article Source Type: news

Lung cancer among native and foreign-born Swedes: histopathology, treatment, and survival.
CONCLUSION: FBS patients were significantly younger than NatS at diagnosis, and female FBS lived longer than female NatS, but otherwise there were no significant differences between NatS and FBS patients with LC regarding diagnosis, treatment, and survival. PMID: 27556916 [PubMed - as supplied by publisher]
Source: Acta Oncologica - August 23, 2016 Category: Cancer & Oncology Authors: Koyi H, Hillerdal G, Andersson O, Högberg H, Brandén E Tags: Acta Oncol Source Type: research

Could molecular pathology testing in lung cancer be more cost-effective?
Conclusions Testing only patients being considered for EGFR and ALK inhibitors represented small savings; more significant savings would be achievable if testing algorithms used known associations between clinical biomarkers.
Source: Journal of Clinical Pathology - September 19, 2016 Category: Pathology Authors: Walsh, K., Kheng, Y. C., Oniscu, A., Harrison, D. J., Wallace, W. A. Tags: Immunology (including allergy), Lung cancer (oncology), Molecular biology, Lung cancer (respiratory medicine) Short report Source Type: research

Lambert-eaton myasthenic syndrome in a tertiary neurology centre
Conclusions Our survey confirms that the DELTA-P score is a useful clinical tool to stratify screening for malignancy in patients with LEMS, but suggests that isolated clinical features, such as bulbar or autonomic symptoms, are not necessarily indicative of SCLC-LEMS.
Source: Journal of Neurology, Neurosurgery and Psychiatry - November 14, 2016 Category: Neurosurgery Authors: Ellul, M., Bonello, M., Wieshmann, U. Tags: Immunology (including allergy), Drugs: CNS (not psychiatric), Neuromuscular disease, Radiology, Radiology (diagnostics) ABN Annual Meeting, 17-19 May 2016, The Brighton Centre, Brighton Source Type: research

Diagnosis of lung adenocarcinoma in situ and minimally invasive adenocarcinoma from intraoperative frozen sections: an analysis of 136 cases
Conclusions Diagnosis of AIS and MIA from intraoperative frozen sections is feasible. We provide several modifications that may improve the diagnostic accuracy of intraoperative frozen sections for early-stage lung adenocarcinoma.
Source: Journal of Clinical Pathology - November 17, 2016 Category: Pathology Authors: He, P., Yao, G., Guan, Y., Lin, Y., He, J. Tags: Immunology (including allergy), Lung cancer (oncology), Inflammation, Lung cancer (respiratory medicine) Original article Source Type: research

The New Era of First-Line Immunotherapy for Advanced NSCLC The New Era of First-Line Immunotherapy for Advanced NSCLC
The recent approval of pembrolizumab for first-line NSCLC has ushered in a new era in the treatment for advanced lung cancer, but many questions remain, says Dr Jack West.Medscape Oncology
Source: Medscape Allergy Headlines - January 23, 2017 Category: Allergy & Immunology Tags: Hematology-Oncology Commentary Source Type: news

Practice Pearls: Checkpoint Inhibitors for Lung Cancer Practice Pearls: Checkpoint Inhibitors for Lung Cancer
Dr Mark Kris reviews the challenges of using newly approved immunotherapies for lung cancer patients, especially how to identify patients who will benefit and monitor their progress.Medscape Oncology
Source: Medscape Allergy Headlines - February 23, 2017 Category: Allergy & Immunology Tags: Hematology-Oncology Commentary Source Type: news

Significance of coexistent granulomatous inflammation and lung cancer
Conclusions Incidental detection of granulomatous inflammation in patients undergoing lung resection for cancer, even in a TB-endemic country, may not require any intervention. Such findings may be due to either mycobacterial infection in the past or ‘sarcoid reaction’ to cancer. Although all patients should have their resected specimen sent for acid-fast bacilli culture and followed up until the culture results are reported, the initiation of the management of such patients as per existing lung cancer management guidelines does not affect their outcome adversely.
Source: Journal of Clinical Pathology - March 20, 2017 Category: Pathology Authors: Dagaonkar, R. S., Choong, C. V., Asmat, A. B., Ahmed, D. B. A., Chopra, A., Lim, A. Y. H., Tai, D. Y. H., Kor, A. C., Goh, S. K., Abisheganaden, J., Verma, A. Tags: Open access, Immunology (including allergy), Lung cancer (oncology), Inflammation, Lung cancer (respiratory medicine) Original article Source Type: research

MAGE-A family expression is correlated with poor survival of patients with lung adenocarcinoma: a retrospective clinical study based on tissue microarray
Conclusions Molecular assessment of MAGE-A family members could be considered to improve the prognostic evaluation and to provide a new potential therapeutic strategy for patients with LAC.
Source: Journal of Clinical Pathology - May 22, 2017 Category: Pathology Authors: Sang, M., Gu, L., Yin, D., Liu, F., Lian, Y., Zhang, X., Liu, S., Huang, W., Wu, Y., Shan, B. Tags: Immunology (including allergy), Lung cancer (oncology), Lung cancer (respiratory medicine) Original article Source Type: research

Tumor immune fitness determines survival of lung cancer patients
(La Jolla Institute for Allergy and Immunology) In recent years, immunotherapy, a new form of cancer therapy that rouses the immune system to attack tumor cells, has captivated the public's imagination. When it works, the results are breathtaking. But more often than not it doesn't, and scientists still don't know why.
Source: EurekAlert! - Cancer - June 19, 2017 Category: Cancer & Oncology Source Type: news

Biological monitoring of dermal and air exposure to cobalt at a Swedish hard metal production plant: does dermal exposure contribute to uptake?
ConclusionsOur data suggest that skin exposure to cobalt in the hard metal industry could affect the total uptake at the same order of magnitude as air exposure.
Source: Contact Dermatitis - July 4, 2017 Category: Dermatology Authors: Maria Klasson, Magnus Lindberg, Ing ‐Liss Bryngelsson, Helena Arvidsson, Carin Pettersson, Bente Husby, Håkan Westberg Tags: Original Article Source Type: research